Our Pricing

Weight Loss Clinic Bangor: Professional Medical Support for Sustainable Results

Published: 1 October 2026

Finding a reliable weight loss clinic Bangor residents can trust involves accessing evidence-based treatments under proper medical supervision. Cured Pharmacy connects patients across Bangor and the wider UK with licensed prescribers who assess suitability for prescription weight loss medications including Mounjaro, Wegovy, and Saxenda, all delivered discreetly from our GPhC-registered pharmacy (9012511) with prices starting from £124.99 after your first order discount.

Why Choose a Weight Loss Clinic Bangor Service with Prescription Options

A professional weight loss clinic Bangor service provides structured medical oversight that goes beyond diet advice alone. When lifestyle modifications plateau, prescription medications such as GLP-1 receptor agonists offer clinically proven support. Tirzepatide (Mounjaro) demonstrated average weight reductions of 15-22.5% in the SURPASS-1 to SURPASS-5 trials, whilst semaglutide (Wegovy) achieved 14.9% average weight loss in the STEP 1 trial [1]. These medications work by regulating appetite, slowing gastric emptying, and improving glucose metabolism.

Our UK-registered clinical team conducts a thorough online consultation to assess your medical history, current medications, and weight loss goals. This ensures any prescription issued is safe and appropriate for your individual circumstances. All treatments are MHRA-licensed and dispensed by our superintendent pharmacist Tarun Kumar (GPhC 2233073), maintaining the same clinical standards you would expect from an in-person consultation. Transparent pricing from £124.99 (with code Weightlossnew) means you know costs upfront, with no hidden fees or surprise charges [2].

Prescription Weight Loss Treatments Available Through Our Weight Loss Clinic Bangor Service

Cured Pharmacy offers a comprehensive range of prescription weight loss medications suitable for patients who meet clinical criteria. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist administered as a weekly injection, starting at 2.5 mg and titrating up to a maintenance dose of 5-15 mg depending on response and tolerability. Clinical data shows superior weight loss compared to semaglutide monotherapy, with 91% of participants achieving at least 5% weight reduction [3].

Wegovy (semaglutide) injections begin at 0.25 mg weekly, escalating over 16-20 weeks to the maintenance dose of 2.4 mg. For patients preferring oral administration, Wegovy tablets provide an alternative delivery method with comparable efficacy when dosed correctly. Saxenda (liraglutide) is a daily injection starting at 0.6 mg and increasing to 3 mg, suitable for individuals who prefer more frequent dosing flexibility or have specific contraindications to other GLP-1 agents [4].

Non-Injection Alternatives for Weight Management

For patients seeking non-injectable options, Orlistat (available as generic capsules, Xenical, Alli, or Orlos) works by inhibiting pancreatic lipase, reducing dietary fat absorption by approximately 30%. This mechanism suits individuals following a reduced-calorie diet who need additional support managing fat intake. Foundayo pill offers another oral alternative for those unsuitable for GLP-1 therapies. All options require clinical assessment to determine the most appropriate treatment based on your BMI, comorbidities, and previous weight loss attempts.

How the Weight Loss Clinic Bangor Online Consultation Process Works

Accessing our weight loss clinic Bangor service begins with a free online consultation taking under three minutes to complete. You'll provide details about your current weight, height, medical conditions, medications, and weight loss history. Our UK-registered prescribers review every submission individually—there are no automated approvals. If a prescription medication is deemed suitable and safe, your prescriber will issue a prescription electronically to our pharmacy.

Once approved, your medication is dispensed by our GPhC-registered team and dispatched in 100% discreet packaging via tracked courier. Most orders arrive within 2-3 working days across the UK, including Bangor and surrounding areas. You'll receive clear dosing instructions, injection technique guidance (for injectable treatments), and information on managing potential side effects. Ongoing support is available via phone (+44 116 4646009) or email, and follow-up consultations ensure your treatment remains effective and well-tolerated [5].

Eligibility Criteria for Prescription Weight Loss Medications

NICE guidelines recommend prescription weight loss medications for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities such as type 2 diabetes, hypertension, or obstructive sleep apnoea. Certain medical conditions—including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease—may contraindicate GLP-1 therapies. Your prescriber will assess these factors during the consultation to ensure safe prescribing.

Weight Loss Clinic Bangor Pricing: Transparent Costs with No Hidden Fees

Our weight loss clinic Bangor service guarantees the lowest UK prices with complete transparency. Mounjaro starts from £124.99, Wegovy injections from £124.99, Wegovy tablets from £124.99, Saxenda from £124.99, and Orlistat from £124.99. New patients receive £20 off their first order using code Weightlossnew, bringing the starting price to £124.99 for Mounjaro. These prices include the clinical consultation, prescription, medication, and delivery—no additional charges apply.

Unlike some services that advertise low entry prices but add consultation fees, subscription charges, or delivery costs later, Cured Pharmacy displays the full price upfront. This transparent approach means you can budget accurately and compare services confidently. Our competitive pricing reflects bulk purchasing agreements and streamlined operations, passing savings directly to patients without compromising on clinical quality or regulatory compliance [6].

Managing Side Effects with Weight Loss Clinic Bangor Medical Support

GLP-1 receptor agonists commonly cause gastrointestinal side effects during initial titration, including nausea (reported in 20-44% of patients), diarrhoea, constipation, and abdominal discomfort. These effects typically diminish as your body adapts to the medication over 4-8 weeks. Starting at the lowest effective dose and following the recommended escalation schedule significantly reduces symptom severity. Eating smaller, more frequent meals and avoiding high-fat foods can further minimise nausea [7].

Our weight loss clinic Bangor service provides ongoing clinical support to help you manage side effects effectively. If symptoms persist or worsen, your prescriber may adjust the titration schedule, recommend symptomatic treatments, or consider alternative medications. Serious adverse events—such as severe abdominal pain, persistent vomiting, or signs of pancreatitis—require immediate medical attention. We maintain open communication channels so you can report concerns promptly and receive expert guidance throughout your treatment journey.

Long-Term Safety and Monitoring Requirements

Long-term use of GLP-1 therapies requires periodic monitoring to assess efficacy, tolerability, and metabolic parameters. Patients with type 2 diabetes should monitor blood glucose regularly, as improved glycaemic control may necessitate adjustment of other diabetes medications to prevent hypoglycaemia. Thyroid function tests and pancreatic enzyme levels may be checked if clinically indicated. Weight loss progress should be reviewed every 3-6 months, with treatment continued only if clinically beneficial and well-tolerated. Our prescribers coordinate with your GP where appropriate to ensure integrated care.

Weight Loss Clinic Bangor vs In-Person Services: Convenience and Clinical Quality

Traditional in-person weight loss clinics require travel, appointment scheduling, and waiting room time—barriers that prevent many patients from accessing timely support. Our online weight loss clinic Bangor service removes these obstacles whilst maintaining identical clinical standards. UK-registered prescribers conduct the same thorough assessments as face-to-face consultations, reviewing medical history, contraindications, and treatment goals before issuing any prescription.

Patients benefit from the convenience of completing consultations at home, receiving medications via discreet delivery, and accessing ongoing support remotely. This model suits individuals with mobility limitations, busy schedules, or those preferring privacy around weight management. Our GPhC registration (9012511) and adherence to MHRA regulations ensure every medication dispensed meets UK pharmaceutical standards. You receive genuine, licensed treatments—never counterfeit or unregulated products—backed by professional clinical oversight throughout your weight loss journey [8].

Scientific References

1. Rosenstock, J., Wysham, C., Frías, J. P., Kaneko, S., Lee, C. J., Fernández Landó, L., Mao, H., Cui, X., Karanikas, C. A., & Thieu, V. T. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 1 October 2026]
2. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. [accessed 1 October 2026]
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 1 October 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 1 October 2026]
5. General Pharmaceutical Council. (2022). Standards for registered pharmacies. GPhC. [accessed 1 October 2026]
6. Medicines and Healthcare products Regulatory Agency. (2023). Good practice guidance on the provision of pharmacy services at a distance, including on the internet. MHRA. [accessed 1 October 2026]
7. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 1 October 2026]
8. Royal Pharmaceutical Society. (2022). Professional guidance on the safe and effective prescribing of weight management treatments. RPS. [accessed 1 October 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 1 October 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 1 October 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 1 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.